Related Experiment Video

Updated: Jul 2, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

PTEN and the PI3-kinase pathway in cancer

Nader Chalhoub1, Suzanne J Baker

  • 1Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA. Suzanne.Baker@StJude.org

Annual Review of Pathology
|September 5, 2008
PubMed

Insights

Phosphatidylinositol 3-kinase (PI3K) and PTEN are critical regulators of cell growth and survival. Their frequent mutation in cancers highlights the PI3K pathway as a complex but vital therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • The PI3K pathway, regulated by PI3-kinase (PI3K) and PTEN, controls cell growth, survival, and proliferation.
  • Mutations in PI3K and PTEN are frequent in human cancers, leading to pathway dysregulation and promoting tumorigenesis.
  • PTEN negatively regulates PI3K signaling by dephosphorylating PIP(3) and may possess phosphatase-independent functions.

Purpose of the Study:

  • To review current research on the complex regulation of PTEN and PI3K activity in cancer.
  • To explore potential novel functions of PTEN beyond its enzymatic activity.
  • To examine feedback mechanisms within the PI3K signaling pathway.

Main Methods:

  • Literature review of current scientific work.
  • Analysis of genetic data linking PI3K pathway mutations to cancer.
  • Discussion of biochemical and cellular functions of PTEN and PI3K.

Main Results:

  • The PI3K pathway is central to tumorigenesis due to frequent mutations in key regulators.
  • PTEN's role extends beyond PIP(3) dephosphorylation, including nuclear functions.
  • Complex regulatory networks and feedback loops exist within the PI3K pathway.

Conclusions:

  • The PI3K pathway's significance and complexity present challenges for cancer therapy.
  • Understanding PTEN's multifaceted roles is crucial for developing targeted cancer treatments.
  • Further research into pathway regulation and feedback is needed for effective therapeutic strategies.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...